| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2014PLoSO...9k1759K |
| P356 | DOI | 10.1371/JOURNAL.PONE.0111759 |
| P932 | PMC publication ID | 4219773 |
| P698 | PubMed publication ID | 25369453 |
| P5875 | ResearchGate publication ID | 267870934 |
| P2093 | author name string | Lalita Limaye | |
| Vaijayanti Kale | |||
| Jeetendra Kumar | |||
| Rupali Gurav | |||
| P2860 | cites work | The chemokine receptor CCR7 activates in dendritic cells two signaling modules that independently regulate chemotaxis and migratory speed | Q24298508 |
| Reciprocal crosstalk between dendritic cells and natural killer cells under the effects of PGE2 in immunity and immunopathology | Q26825075 | ||
| Dendritic cells and the control of immunity | Q27860918 | ||
| Immunobiology of dendritic cells | Q29547465 | ||
| Cancer immunotherapy via dendritic cells | Q29615444 | ||
| Taking dendritic cells into medicine | Q29619243 | ||
| Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application | Q33536357 | ||
| Dendritic cells in cancer immunotherapy | Q33932695 | ||
| Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory | Q33946269 | ||
| Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells | Q34141893 | ||
| Mature autologous dendritic cell vaccines in advanced non-small cell lung cancer: a phase I pilot study. | Q35102873 | ||
| Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models. | Q35140717 | ||
| Dendritic cells: limited potential in immunotherapy | Q35913609 | ||
| Trial watch: Dendritic cell-based interventions for cancer therapy | Q36388529 | ||
| Generation, migration and function of circulating dendritic cells | Q36507785 | ||
| Cancer immunotherapy by dendritic cells | Q37272237 | ||
| Costimulation of dectin-1 and DC-SIGN triggers the arachidonic acid cascade in human monocyte-derived dendritic cells | Q39994877 | ||
| RNA loading of leukemic antigens into cord blood-derived dendritic cells for immunotherapy. | Q40252007 | ||
| Long-term culture of human CD34(+) progenitors with FLT3-ligand, thrombopoietin, and stem cell factor induces extensive amplification of a CD34(-)CD14(-) and a CD34(-)CD14(+) dendritic cell precursor. | Q40820456 | ||
| Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
| Dendritic cells in cancer immunotherapy: vaccines or autologous transplants? | Q41520681 | ||
| The disabled dendritic cell | Q43568386 | ||
| The first 1000 dendritic cell vaccinees. | Q50736412 | ||
| A simple two-step culture system for the large-scale generation of mature and functional dendritic cells from umbilical cord blood CD34+ cells. | Q50743099 | ||
| Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis. | Q51126171 | ||
| Expansion of dendritic cell precursors from human CD34(+) progenitor cells isolated from healthy donor blood; growth factor combination determines proliferation rate and functional outcome. | Q52011374 | ||
| Selective generation of different dendritic cell precursors from CD34+ cells by interleukin-6 and interleukin-3. | Q52087796 | ||
| Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. | Q52905310 | ||
| Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma Patients | Q58619964 | ||
| A Critical Role for Prostaglandin E2 in Podosome Dissolution and Induction of High-Speed Migration during Dendritic Cell Maturation | Q58620009 | ||
| The JAM test. A simple assay for DNA fragmentation and cell death | Q67814814 | ||
| Stem cell factor and the regulation of dendritic cell production from CD34+ progenitors in bone marrow and cord blood | Q71098982 | ||
| Migration of human dendritic cells after injection in patients with metastatic malignancies | Q77804763 | ||
| Cyclooxygenase-2 inhibition attenuates antibody responses against human papillomavirus-like particles | Q79370189 | ||
| The JAM Test and its daughter P-JAM: simple tests of DNA fragmentation to measure cell death and stasis | Q80092940 | ||
| In vitro generation of functional dendritic cells from human umbilical cord blood CD34+ cells by a 2-step culture method | Q80995433 | ||
| A large number of mature and functional dendritic cells can be efficiently generated from umbilical cord blood-derived mononuclear cells by a simple two-step culture method | Q84289985 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dendritic cell | Q506253 |
| immunotherapy | Q1427096 | ||
| P304 | page(s) | e111759 | |
| P577 | publication date | 2014-11-04 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Exogenous addition of arachidonic acid to the culture media enhances the functionality of dendritic cells for their possible use in cancer immunotherapy | |
| P478 | volume | 9 |
| Q36093456 | Umbilical cord blood-derived CD11c(+) dendritic cells could serve as an alternative allogeneic source of dendritic cells for cancer immunotherapy | cites work | P2860 |
Search more.